l.aaltonen
TL3 Regular · Rimini, IT
Clinician. Posts general information only, and says so every time.
Joined 4 January 2025 · last posted 1d · groups: clinicians
136 posts, newest first. Showing up to 150.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #91 · Analytics › Impurities & related substances · 27 Jul 2026 · 0 likes Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #61 · Practice › Side effects · 19 Jul 2026 · 6 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Tracking a shortage from primary sources rather than rumour Replied, post #111 · Access › Shortages · 19 Jul 2026 · 2 likes Worth separating two things that post #107 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Tirzepatide storage and stability: what is published versus what is assumed Replied, post #21 · Compounds › Tirzepatide · 16 Jul 2026 · 32 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Distinguishing a red flag from an inconvenience — a second dataset Started this topic · Sourcing › Red flags · 16 Jul 2026 · 1 like On the subject in the title: Distinguishing a red flag from an inconvenience — a second dataset Working notes rather than a conclusion. A logistics question, since the…
-
Insurance and replacement policies, compared Replied, post #89 · Sourcing › Logistics · 15 Jul 2026 · 7 likes This follows post #86 rather than contradicting it. At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #101 · Evidence › Journal club · 12 Jul 2026 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Impurity thresholds: where the common numbers come from Replied, post #3 · Analytics › Impurities & related substances · 12 Jul 2026 · 3 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #68 · Access › International · 9 Jul 2026 · 5 likes Insurance and coverage: coverage decisions are national. A compound approved in one country might not be covered by insurance in another. Checking both approval and…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #18 · Analytics › Home & field testing · 9 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Coming back to: A structured critique template this community uses Replied, post #53 · Evidence › Study critique · 8 Jul 2026 · 5 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
How much context is too much context in a first post? Replied, post #33 · Start Here › How to Ask · 7 Jul 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #22 · Compounds › Secretagogues & GH axis · 4 Jul 2026 · 11 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #96 · Evidence › Preprints · 4 Jul 2026 · 4 likes Picking up post #93: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Restarting after a long gap: what the labelling implies Replied, post #7 · Practice › Dosing & titration · 30 Jun 2026 · 16 likes This follows post #4 rather than contradicting it. Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives.…
-
Journal club: what we got wrong in an earlier session Replied, post #30 · Evidence › Journal club · 26 Jun 2026 · 6 likes Worth separating two things that post #26 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #36 · Research Methods › Statistics · 25 Jun 2026 · 18 likes Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #39 · Start Here › Welcome · 24 Jun 2026 · 10 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #4 · Nutrition & Training › Protein & intake · 23 Jun 2026 · 8 likes This follows post #3 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
CJC-1295 with and without DAC: what the modification does Replied, post #89 · Compounds › Secretagogues & GH axis · 20 Jun 2026 · 2 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
-
Revisiting: Bioimpedance and hydration: why the number moves Replied, post #3 · marked as the solution · Outcomes › Body composition · 19 Jun 2026 · 10 likes Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat. That distinction might matter but requires different imaging to measure.
-
Injecting into an area that has become firm: why not to Replied, post #64 · Practice › Administration · 13 Jun 2026 · 1 like Picking up post #61: that is the part I would want checked first. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #80 · Practice › Reconstitution · 12 Jun 2026 · 26 likes Coming back to post #78, because the follow-up matters more than the original answer. How much of the diluent volume the powder itself displaces: for a small peptide…
-
Reading U-100 graduations, with a conversion table Replied, post #32 · Devices › Syringes & needles · 8 Jun 2026 · 4 likes Fixed versus detachable needles: insulin syringes usually have fixed needles (no dead volume loss to the hub). Luer-lock syringes use detachable needles (more dead…
-
Injecting into an area that has become firm: why not to Replied, post #28 · Practice › Administration · 7 Jun 2026 · 7 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #21 · Sourcing › Red flags · 3 Jun 2026 · 28 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #24 · Access › Pricing · 31 May 2026 · 1 like post #23 answers the question as asked. The question underneath it is different. Price variation between pharmacies: identical prescriptions can cost different amounts…
-
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #24 · Sourcing › Logistics · 31 May 2026 · 30 likes post #23 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Analytical identity of BPC-157: a 15-mer with a simple mass — does this still hold? Replied, post #26 · Compounds › Repair & healing peptides · 20 May 2026 · 7 likes Stability of BPC-157 in solution: what has been measured in published work covers specific formulations under specific conditions. Extrapolating to a reconstituted…
-
Journal club: LEADER as the historical anchor Replied, post #75 · Evidence › Journal club · 17 May 2026 · 27 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #28 · Compounds › Semaglutide · 16 May 2026 · 11 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #61 · Evidence › Journal club · 12 May 2026 · 0 likes On post #57 — agreed on the reasoning, with one qualification. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #54 · Compounds › Semaglutide · 11 May 2026 · 4 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
What a good consultation looks like from the other side Replied, post #39 · Clinical › Prescriber conversations · 10 May 2026 · 19 likes Worth separating two things that post #35 runs together. Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after…
-
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #55 · Practice › Storage & stability · 4 May 2026 · 0 likes Temperature excursions: if a vial sat at room temperature for a time, the question is whether the excursion was long enough to cause damage. Hours at room temperature…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #109 · Practice › Storage & stability · 3 May 2026 · 0 likes This follows post #106 rather than contradicting it. I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence…
-
Citation sweep results: how many references did not say what was claimed Replied, post #86 · Meta › Wiki maintenance · 29 Apr 2026 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #59 · Evidence › Trials · 25 Apr 2026 · 17 likes Worth separating two things that post #55 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Spike-and-recover accuracy for a peptide assay Replied, post #59 · Analytics › Method validation · 9 Apr 2026 · 31 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #54 · Data & Tools › Calculators · 8 Apr 2026 · 5 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
[2026 update] Hello from a laboratory that does not do peptides Replied, post #3 · Lounge › Introductions · 6 Apr 2026 · 13 likes Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #4 · Analytics › Method validation · 4 Apr 2026 · 2 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Reused chromatograms across lots: how to spot it Replied, post #30 · Analytics › COA interpretation · 30 Mar 2026 · 29 likes Worth separating two things that post #26 runs together. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #26 · Practice › Administration · 24 Mar 2026 · 2 likes Worth separating two things that post #22 runs together. Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #76 · Evidence › Study critique · 22 Feb 2026 · 0 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #47 · Practice › Side effects · 17 Feb 2026 · 8 likes Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated lipase). If this constellation of findings appears, stopping…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #126 · Analytics › Mass spectrometry · 16 Feb 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #41 · Regional › UK & Ireland · 14 Feb 2026 · 9 likes Private prescribing is legal and widespread, including through remote consultation. Pharmacies must satisfy themselves that a prescription is clinically appropriate.…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #9 · Practice › Reconstitution · 9 Feb 2026 · 8 likes On post #5 — agreed on the reasoning, with one qualification. Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial"…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #34 · Regional › UK & Ireland · 8 Feb 2026 · 16 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] What a purity-only report leaves out Replied, post #17 · Sourcing › Independent verification · 5 Feb 2026 · 11 likes post #16 is right about the mechanism and I think understates the practical bit. Medutest: combined purity and identity reporting. Appears throughout vendor…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #17 · Evidence › Trials · 29 Jan 2026 · 4 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Coming back to: Reading a supplier's product description as a marketing document Replied, post #6 · Compounds › Other compounds · 25 Jan 2026 · 2 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #21 · Practice › Storage & stability · 10 Jan 2026 · 31 likes post #20 is right about the mechanism and I think understates the practical bit. I want to gently push back on the reply above about storage extrapolation. The advice…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #27 · Practice › Side effects · 4 Jan 2026 · 4 likes Coming back to post #25, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Reverse causation in a cohort study of weight and outcome Replied, post #14 · Evidence › Study critique · 3 Jan 2026 · 3 likes This follows post #11 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
What "verified" means on our vendor pages, stated narrowly Replied, post #14 · Sourcing › Vendor reports · 27 Dec 2025 · 25 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Substitution between formats during a shortage Replied, post #120 · Access › Shortages · 20 Dec 2025 · 27 likes Allocation and rationing: during severe shortages, suppliers might ration allocation to prescribers. Understanding rationing policies from your prescriber matters for…
-
Tracking a preprint to publication: a worked example Replied, post #119 · Evidence › Preprints · 12 Dec 2025 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
Robustness: the parameters worth deliberately varying Replied, post #47 · Analytics › Method validation · 7 Dec 2025 · 2 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Journal club: LEADER as the historical anchor Replied, post #9 · Evidence › Journal club · 3 Dec 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #49 · Practice › Reconstitution · 25 Nov 2025 · 8 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Long-time reader, first-time poster Replied, post #16 · Lounge › Introductions · 14 Nov 2025 · 1 like post #15 answers the question as asked. The question underneath it is different. Privacy: share only what you are comfortable making permanent and public. An…
-
Adolescents: a distinct evidence base — one year on Replied, post #33 · Clinical › Special populations · 12 Nov 2025 · 0 likes I read post #31 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #80 · Start Here › How to Ask · 10 Nov 2025 · 16 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #81 · Start Here › How to Ask · 5 Nov 2025 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Comparing my trajectory with the trial curves, carefully Replied, post #71 · Outcomes › Progress reports · 4 Nov 2025 · 0 likes Worth separating two things that post #67 runs together. Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool;…
-
EMA product information as a primary source Replied, post #18 · Regional › European Union · 31 Oct 2025 · 7 likes post #17 is right about the mechanism and I think understates the practical bit. Reimbursement varies substantially by member state. Some (Germany, France, Netherlands)…
-
Liver enzymes drifting down and what that usually means Replied, post #22 · Clinical › Bloodwork · 26 Oct 2025 · 15 likes Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #82 · Analytics › Home & field testing · 21 Oct 2025 · 5 likes Worth separating two things that post #78 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #67 · Start Here › Welcome · 18 Oct 2025 · 9 likes Off-topic posts that do not belong here belong in the Lounge instead. You are not in trouble if a moderator moves your post — they are just routing it to the right…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #68 · Lounge › Off topic · 1 Oct 2025 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #76 · Practice › Administration · 24 Sep 2025 · 0 likes Coming back to post #74, because the follow-up matters more than the original answer. Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #22 · Evidence › Study critique · 13 Sep 2025 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Publication bias: a single published positive trial is weaker evidence than multiple…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #13 · Evidence › Study critique · 12 Sep 2025 · 9 likes Generalisability: do the inclusion/exclusion criteria narrow the population so much that results do not apply to real people asking about it? This is a fair criticism…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #47 · Practice › Storage & stability · 6 Sep 2025 · 0 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #12 · Compounds › Tirzepatide · 4 Sep 2025 · 20 likes post #11 is right about the mechanism and I think understates the practical bit. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #52 · Analytics › HPLC & UHPLC · 29 Aug 2025 · 14 likes This follows post #49 rather than contradicting it. Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #40 · Compounds › Secretagogues & GH axis · 26 Aug 2025 · 6 likes Pulsatile secretion matters because growth hormone is secreted in pulses, not continuously. A single post-dose growth hormone level is nearly uninterpretable. Assessing…
-
Follow-up: Glucagon receptor agonism in a weight-loss compound Replied, post #4 · Pharmacology › Receptor biology · 24 Aug 2025 · 31 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
Which panel is worth repeating and which is worth ignoring Replied, post #90 · Clinical › Bloodwork · 21 Aug 2025 · 1 like HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
What a documentation review can and cannot tell you Replied, post #76 · Sourcing › Independent verification · 16 Aug 2025 · 23 likes post #75 is right about the mechanism and I think understates the practical bit. Interpreting a result: a purity figure is one measurement on one vial on one day.…
-
Are there stupid questions here? A staff answer, at length Replied, post #60 · Start Here › Welcome · 11 Aug 2025 · 0 likes Worth separating two things that post #56 runs together. Trust levels accumulate over time and they give you access to small things like the ability to edit your own…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #6 · Sourcing › Vendor reports · 9 Aug 2025 · 9 likes This follows post #3 rather than contradicting it. Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is…
-
Lyophilisation and why the cake looks the way it does Replied, post #11 · Pharmacology › Formulation chemistry · 7 Aug 2025 · 10 likes I read post #9 twice before replying, because I had assumed the opposite. Emulsification and suspensions: some formulations are emulsions or suspensions rather than…
-
A ten-fold dose error caught before injection — one year on Replied, post #61 · Devices › Syringes & needles · 2 Aug 2025 · 5 likes post #60 is right about the mechanism and I think understates the practical bit. Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL.…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #48 · Access › Insurance & coverage · 18 Jul 2025 · 0 likes Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not for weight management. The indication matters and…
-
Revisiting: What to include when your question involves arithmetic Replied, post #20 · Start Here › How to Ask · 14 Jul 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
A field-by-field walk through a certificate of analysis Replied, post #7 · Analytics › COA interpretation · 14 Jul 2025 · 0 likes This follows post #4 rather than contradicting it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide…
-
Forced degradation studies: designing one that is informative — does this still hold? Replied, post #30 · Analytics › Method validation · 4 Jul 2025 · 28 likes This follows post #27 rather than contradicting it. System suitability: injections run at the start of a batch to establish that the instrument and column are…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #80 · Practice › Reconstitution · 3 Jul 2025 · 10 likes Worth separating two things that post #76 runs together. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #63 · Compounds › Repair & healing peptides · 27 Jun 2025 · 5 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Asking about a compound your prescriber has not heard of Replied, post #76 · Clinical › Prescriber conversations · 25 Jun 2025 · 1 like I read post #74 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #14 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 15 likes Reversed-phase separates on hydrophobicity. A peptide is retained on a non-polar stationary phase and eluted by increasing organic solvent. For peptides the mobile…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #4 · Evidence › Meta-analyses · 14 Jun 2025 · 23 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Coming back to: Getting a referral rather than a refusal Replied, post #68 · Clinical › Prescriber conversations · 14 Jun 2025 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #105 · Access › Insurance & coverage · 14 Jun 2025 · 0 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 12 Jun 2025 · 12 likes post #72 is right about the mechanism and I think understates the practical bit. For anyone arriving from searches on "amylin agonist": this subcategory discusses…
-
Antibiotics and a course of something with delayed emptying Replied, post #59 · Practice › Interactions · 7 Jun 2025 · 4 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #55 · Sourcing › Independent verification · 5 Jun 2025 · 0 likes Cost and turnaround: different services have different pricing and turnaround times. Janoshik's turnaround is weeks by mail; VendorInvestigate documentation review is…
-
Checking someone else's arithmetic: a worked example thread Replied, post #47 · Practice › Reconstitution · 13 May 2025 · 25 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
A well-designed study with a badly written abstract Replied, post #60 · Evidence › Study critique · 4 May 2025 · 21 likes Picking up post #57: that is the part I would want checked first. Building consensus on which criticisms matter: if everyone agrees that the sample size is small but…
-
A page that has drifted out of date and needs a maintainer Replied, post #98 · Documentation › Wiki requests · 3 May 2025 · 0 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
[2026 update] US compounding rules and how they changed Replied, post #11 · Regional › North America · 2 May 2025 · 27 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #32 · Compounds › Retatrutide · 30 Apr 2025 · 0 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #25 · Compounds › Retatrutide · 14 Mar 2025 · 0 likes What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose response in diverse populations, whether the heart-rate…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #2 · Evidence › Journal club · 11 Mar 2025 · 0 likes On the opening post — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #22 · Clinical › Comorbidities · 26 Feb 2025 · 24 likes On post #18 — agreed on the reasoning, with one qualification. PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin…
-
Semaglutide in people without diabetes: what the evidence base looks like Replied, post #7 · Compounds › Semaglutide · 20 Feb 2025 · 18 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
-
When "no data" is the complete and final answer Replied, post #96 · Compounds › Other compounds · 18 Feb 2025 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #13 · Analytics › Mass spectrometry · 17 Feb 2025 · 0 likes Calibration matters: a high-resolution instrument out of calibration can report mass with ppm error large enough to be uninformative. Check when the instrument was last…
-
Introducing myself and asking whether my planned first topic belongs anywhere Replied, post #4 · Start Here › Welcome · 9 Feb 2025 · 7 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #2 · Access › Pricing · 27 Jan 2025 · 2 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live.
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #21 · Sourcing › Vendor reports · 9 Jan 2025 · 0 likes This follows post #18 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #82 · Compounds › Oral incretins · 27 Dec 2024 · 5 likes PIONEER 6 was a cardiovascular safety trial for oral semaglutide, not an efficacy trial. Non-inferiority for safety was demonstrated. The point estimates favoured the…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #53 · Compounds › Oral incretins · 26 Dec 2024 · 1 like post #52 answers the question as asked. The question underneath it is different. Oral bioavailability is variable between people. Some people absorb well; others absorb…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #108 · Compounds › Tirzepatide · 25 Dec 2024 · 25 likes I read post #106 twice before replying, because I had assumed the opposite. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on satiety…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #29 · Data & Tools › Calculators · 24 Dec 2024 · 4 likes Coming back to post #27, because the follow-up matters more than the original answer. The calculators maintained on this site are open-source and verifiable. They are…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #24 · Analytics › Mass spectrometry · 23 Dec 2024 · 15 likes On post #20 — agreed on the reasoning, with one qualification. What mass accuracy establishes: the measured mass is consistent with a specific composition. What it does…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #49 · Nutrition & Training › Protein & intake · 10 Dec 2024 · 14 likes This follows post #46 rather than contradicting it. Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #19 · Devices › Cold chain · 8 Dec 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #76 · Analytics › Method validation · 19 Nov 2024 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #5 · Sourcing › Vendor reports · 11 Nov 2024 · 12 likes post #4 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
US compounding rules and how they changed Replied, post #62 · Regional › North America · 8 Nov 2024 · 6 likes Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #18 · Sourcing › Independent verification · 3 Nov 2024 · 14 likes I read post #16 twice before replying, because I had assumed the opposite. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #5 · Meta › Wiki maintenance · 9 Oct 2024 · 0 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #15 · Compounds › Semaglutide · 24 Sep 2024 · 4 likes I read post #13 twice before replying, because I had assumed the opposite. The SELECT trial changed the positioning because it was the first cardiovascular outcome…
-
Reading a meta-analysis you disagree with, fairly Replied, post #13 · Evidence › Meta-analyses · 26 Aug 2024 · 15 likes Worth separating two things that post #9 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #18 · Sourcing › Independent verification · 26 Aug 2024 · 13 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Correlation in a self-tracked dataset: what it can support Replied, post #146 · Research Methods › Statistics · 25 Aug 2024 · 28 likes I read post #144 twice before replying, because I had assumed the opposite. Confidence intervals: rather than a single point estimate, a range of plausible values. A…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #17 · Compounds › Semaglutide · 22 Aug 2024 · 0 likes post #16 is right about the mechanism and I think understates the practical bit. Approved indications differ by jurisdiction and change. As of mid-2026 the…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #42 · Practice › Dosing & titration · 10 Aug 2024 · 2 likes Picking up post #39: that is the part I would want checked first. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose…
-
Guidelines revision: what changed and why Replied, post #116 · Meta › Announcements · 28 Jul 2024 · 6 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #25 · Safety › Contraindications · 23 Jul 2024 · 23 likes This follows post #22 rather than contradicting it. I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The…
-
Reading a meta-analysis you disagree with, fairly Replied, post #4 · Evidence › Meta-analyses · 7 Jul 2024 · 8 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
Oral contraceptives and delayed emptying: what the data shows Replied, post #14 · Practice › Interactions · 7 Jul 2024 · 32 likes post #13 answers the question as asked. The question underneath it is different. Metformin: commonly co-administered and relevant to gastrointestinal tolerability.…